FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1872-1879 June 17, 1999 Number 24 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The detection of pheochromocytomas in patients at risk for these tumors, such as patients with von Hippel–Lindau disease or multiple endocrine neoplasia type 2 (MEN-2), is hindered by the inadequate sensitivity of commonly available biochemical tests. In this study we evaluated measurements of plasma normetanephrine and metanephrine for detecting pheochromocytomas in patients with von Hippel–Lindau disease or MEN-2.

Methods We studied 26 patients with von Hippel–Lindau disease and 9 patients with MEN-2 who had histologically verified pheochromocytomas and 50 patients with von Hippel–Lindau disease or MEN-2 who had no radiologic evidence of pheochromocytoma. Von Hippel–Lindau disease and MEN-2 were diagnosed on the basis of germ-line mutations of the appropriate genes. The plasma concentrations of normetanephrine and metanephrine were compared with the plasma concentrations of catecholamines (norepinephrine and epinephrine) and urinary excretion of catecholamines, metanephrines, and vanillylmandelic acid.

Results The sensitivity of measurements of plasma normetanephrine and metanephrine for the detection of tumors was 97 percent, whereas the other biochemical tests had a sensitivity of only 47 to 74 percent. All patients with MEN-2 had high plasma concentrations of metanephrine, whereas the patients with von Hippel–Lindau disease had almost exclusively high plasma concentrations of only normetanephrine. One patient with von Hippel–Lindau disease had a normal plasma normetanephrine concentration; this patient had a very small adrenal tumor (<1 cm). The high sensitivity of measurements of plasma normetanephrine and metanephrine was accompanied by a high level of specificity (96 percent).

Conclusions Measurements of plasma normetanephrine and metanephrine are useful in screening for pheochromocytomas in patients with a familial predisposition to these tumors.

Source Information

From the Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke (G.E., D.S.G.), the Urologic Oncology Branch, National Cancer Institute (W.M.L., M.M.W.), and the Hypertension Endocrine Branch, National Heart, Lung, and Blood Institute (H.R.K.) — all at the National Institutes of Health, Bethesda, Md.; and the Department of General Internal Medicine, St. Radboud University Hospital, Nijmegen, the Netherlands (J.W.M.L.).

Address reprint requests to Dr. Eisenhofer at Bldg. 10, Rm. 6N252, National Institutes of Health, 10 Center Dr., MSC-1620, Bethesda, MD 20892-1620, or at ge{at}box-g.nih.gov.

Full Text of this Article

This article has been cited by other articles:

• Frankenstein, L., Zugck, C., Schellberg, D., Nelles, M., Froehlich, H., Katus, H., Remppis, A. (2009). Prevalence and prognostic significance of adrenergic escape during chronic {beta}-blocker therapy in chronic heart failure. Eur J Heart Fail 11: 178-184 [Abstract] [Full Text]  
• Eisenhofer, G., Huynh, T.-T., Elkahloun, A., Morris, J. C., Bratslavsky, G., Linehan, W. M., Zhuang, Z., Balgley, B. M., Lee, C. S., Mannelli, M., Lenders, J. W. M., Bornstein, S. R., Pacak, K. (2008). Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma. Am. J. Physiol. Endocrinol. Metab. 295: E1223-E1233 [Abstract] [Full Text]  
• Ilias, I., Chen, C. C., Carrasquillo, J. A., Whatley, M., Ling, A., Lazurova, I., Adams, K. T., Perera, S., Pacak, K. (2008). Comparison of 6-18F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma. JNM 49: 1613-1619 [Abstract] [Full Text]  
• Yuan, W., Wang, W., Cui, B., Su, T., Ge, Y., Jiang, L., Zhou, W., Ning, G. (2008). Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry. Endocr Relat Cancer 15: 343-350 [Abstract] [Full Text]  
• Peaston, R. T, Ball, S. (2008). Biochemical detection of phaeochromocytoma: why are we continuing to ignore the evidence?. Ann Clin Biochem 45: 6-10 [Abstract] [Full Text]  
• Karagiannis, A., Mikhailidis, D. P, Athyros, V. G, Harsoulis, F. (2007). Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 14: 935-956 [Abstract] [Full Text]  
• Pacak, K. (2007). Preoperative Management of the Pheochromocytoma Patient. J. Clin. Endocrinol. Metab. 92: 4069-4079 [Abstract] [Full Text]  
• Brouwers, F. M, Glasker, S., Nave, A. F, Vortmeyer, A. O, Lubensky, I., Huang, S., Abu-Asab, M. S, Eisenhofer, G., Weil, R. J, Park, D. M, Linehan, W M., Pacak, K., Zhuang, Z. (2007). Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B. Endocr Relat Cancer 14: 463-471 [Abstract] [Full Text]  
• d'Herbomez, M., Forzy, G., Bauters, C., Tierny, C., Pigny, P., Carnaille, B., Pattou, F., Wemeau, J.-L., Rouaix, N. (2007). An analysis of the biochemical diagnosis of 66 pheochromocytomas. Eur J Endocrinol 156: 569-575 [Abstract] [Full Text]  
• Kaji, P., Carrasquillo, J. A, Linehan, W M., Chen, C. C, Eisenhofer, G., Pinto, P. A, Lai, E. W, Pacak, K. (2007). The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. Eur J Endocrinol 156: 483-487 [Abstract] [Full Text]  
• Mitchell, I. C., Nwariaku, F. E. (2007). Adrenal Masses in the Cancer Patient: Surveillance or Excision. The Oncologist 12: 168-174 [Abstract] [Full Text]  
• Jimenez, C., Cote, G., Arnold, A., Gagel, R. F. (2006). Should Patients with Apparently Sporadic Pheochromocytomas or Paragangliomas be Screened for Hereditary Syndromes?. J. Clin. Endocrinol. Metab. 91: 2851-2858 [Abstract] [Full Text]  
• Iliopoulos, O., Chan-Smutko, G., Gonzalez, R. G., Louis, D. N., Stone, J. R. (2006). Case records of the Massachusetts General Hospital. Case 23-2006. A 36-year-old man with numbness in the right hand and hypertension.. NEJM 355: 394-402 [Full Text]  
• Cecchin, D, Lumachi, F, Marzola, M C, Opocher, G, Scaroni, C, Zucchetta, P, Mantero, F, Bui, F (2006). A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.. Endocr Relat Cancer 13: 525-533 [Abstract] [Full Text]  
• Honda, E., Ono, K., Kataoka, S., Inenaga, K. (2006). Activation of subfornical organ neurons in rats through pre- and postsynaptic {alpha}-adrenoceptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R1646-R1653 [Abstract] [Full Text]  
• Unger, N., Pitt, C., Schmidt, I. L., Walz, M. K, Schmid, K. W, Philipp, T., Mann, K., Petersenn, S. (2006). Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass.. Eur J Endocrinol 154: 409-417 [Abstract] [Full Text]  
• Huynh, T.-T., Pacak, K., Brouwers, F. M, Abu-Asab, M. S, Worrell, R. A, Walther, M. M, Elkahloun, A. G, Goldstein, D. S, Cleary, S., Eisenhofer, G. (2005). Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Eur J Endocrinol 153: 551-563 [Abstract] [Full Text]  
• Vogel, T. W. A., Brouwers, F. M., Lubensky, I. A., Vortmeyer, A. O., Weil, R. J., Walther, M. M., Oldfield, E. H., Linehan, W. M., Pacak, K., Zhuang, Z. (2005). Differential Expression of Erythropoietin and Its Receptor in von Hippel-Lindau-Associated and Multiple Endocrine Neoplasia Type 2-Associated Pheochromocytomas. J. Clin. Endocrinol. Metab. 90: 3747-3751 [Abstract] [Full Text]  
• Eisenhofer, G., Goldstein, D. S., Sullivan, P., Csako, G., Brouwers, F. M., Lai, E. W., Adams, K. T., Pacak, K. (2005). Biochemical and Clinical Manifestations of Dopamine-Producing Paragangliomas: Utility of Plasma Methoxytyramine. J. Clin. Endocrinol. Metab. 90: 2068-2075 [Abstract] [Full Text]  
• Eisenhofer, G., Lenders, J. W.M., Goldstein, D. S., Mannelli, M., Csako, G., Walther, M. M., Brouwers, F. M., Pacak, K. (2005). Pheochromocytoma Catecholamine Phenotypes and Prediction of Tumor Size and Location by Use of Plasma Free Metanephrines. Clin. Chem. 51: 735-744 [Abstract] [Full Text]  
• Garber, J. E., Offit, K. (2005). Hereditary Cancer Predisposition Syndromes. JCO 23: 276-292 [Abstract] [Full Text]  
• Eisenhofer, G., Kopin, I. J., Goldstein, D. S. (2004). Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine. Pharmacol. Rev. 56: 331-349 [Abstract] [Full Text]  
• Neumann, H. P. H., Pawlu, C., Peczkowska, M., Bausch, B., McWhinney, S. R., Muresan, M., Buchta, M., Franke, G., Klisch, J., Bley, T. A., Hoegerle, S., Boedeker, C. C., Opocher, G., Schipper, J., Januszewicz, A., Eng, C., for the European-American Paraganglioma Study Grou, (2004). Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene Mutations. JAMA 292: 943-951 [Abstract] [Full Text]  
• Sawka, A. M., Gafni, A., Thabane, L., Young, W. F. Jr. (2004). The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma. J. Clin. Endocrinol. Metab. 89: 2859-2866 [Abstract] [Full Text]  
• Ilias, I., Yu, J., Carrasquillo, J. A., Chen, C. C., Eisenhofer, G., Whatley, M., McElroy, B., Pacak, K. (2003). Superiority of 6-[18F]-Fluorodopamine Positron Emission Tomography Versus [131I]-Metaiodobenzylguanidine Scintigraphy in the Localization of Metastatic Pheochromocytoma. J. Clin. Endocrinol. Metab. 88: 4083-4087 [Abstract] [Full Text]  
• Bravo, E. L., Tagle, R. (2003). Pheochromocytoma: State-of-the-Art and Future Prospects. Endocr. Rev. 24: 539-553 [Abstract] [Full Text]  
• Eisenhofer, G., Goldstein, D. S., Walther, M. M., Friberg, P., Lenders, J. W. M., Keiser, H. R., Pacak, K. (2003). Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results. J. Clin. Endocrinol. Metab. 88: 2656-2666 [Abstract] [Full Text]  
• Eisenhofer, G. (2003). Biochemical Diagnosis of Pheochromocytoma--Is it Time to Switch to Plasma-Free Metanephrines?. J. Clin. Endocrinol. Metab. 88: 550-552 [Full Text]  
• Sawka, A. M., Jaeschke, R., Singh, R. J., Young, W. F. Jr. (2003). A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines. J. Clin. Endocrinol. Metab. 88: 553-558 [Abstract] [Full Text]  
• Neumann, H. P. H., Lenders, J. W. M., Pacak, K., Eisenhofer, G. (2002). Imaging vs Biochemical Testing for Pheochromocytoma. JAMA 288: 314-315 [Full Text]  
• Kashyap, A S, Kashyap, S (2002). von Hippel-Lindau disease complicated by pheochromocytoma. Postgrad. Med. J. 78: 443-443 [Full Text]  
• Baghai, M., Thompson, G. B., Young, W. F. Jr, Grant, C. S., Michels, V. V., van Heerden, J. A. (2002). Pheochromocytomas and Paragangliomas in von Hippel-Lindau Disease: A Role for Laparoscopic and Cortical-Sparing Surgery. Arch Surg 137: 682-689 [Abstract] [Full Text]  
• Weise, M., Merke, D. P., Pacak, K., Walther, M. M., Eisenhofer, G. (2002). Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma. J. Clin. Endocrinol. Metab. 87: 1955-1960 [Abstract] [Full Text]  
• Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., Eisenhofer, G. (2002). Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?. JAMA 287: 1427-1434 [Abstract] [Full Text]  
• Taylor, R. L., Singh, R. J. (2002). Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Analysis of Urinary Conjugated Metanephrine and Normetanephrine for Screening of Pheochromocytoma. Clin. Chem. 48: 533-539 [Abstract] [Full Text]  
• Crockett, D. K., Frank, E. L., Roberts, W. L. (2002). Rapid Analysis of Metanephrine and Normetanephrine in Urine by Gas Chromatography-Mass Spectrometry. Clin. Chem. 48: 332-337 [Abstract] [Full Text]  
• Pacak, K., Goldstein, D. S., Doppman, J. L., Shulkin, B. L., Udelsman, R., Eisenhofer, G. (2001). A ""Pheo"" Lurks: Novel Approaches for Locating Occult Pheochromocytoma. J. Clin. Endocrinol. Metab. 86: 3641-3646 [Abstract] [Full Text]  
• Eisenhofer, G. (2001). Free or Total Metanephrines for Diagnosis of Pheochromocytoma: What Is the Difference?. Clin. Chem. 47: 988-989 [Full Text]  
• Roden, M., Raffesberg, W., Raber, W., Bernroider, E., Niederle, B., Waldhausl, W., Gasic, S. (2001). Quantification of Unconjugated Metanephrines in Human Plasma without Interference by Acetaminophen. Clin. Chem. 47: 1061-1067 [Abstract] [Full Text]  
• Eisenhofer, G., Walther, M. M., Huynh, T.-T., Li, S.-T., Bornstein, S. R., Vortmeyer, A., Mannelli, M., Goldstein, D. S., Linehan, W. M., Lenders, J. W. M., Pacak, K. (2001). Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes. J. Clin. Endocrinol. Metab. 86: 1999-2008 [Abstract] [Full Text]  
• Conlin, P. R., Faquin, W. C. (2001). Case 13-2001- A 19-Year-Old Man with Bouts of Hypertension and Severe Headaches. NEJM 344: 1314-1320 [Full Text]  
• Rao, F., Keiser, H. R., O'Connor, D. T. (2000). Malignant Pheochromocytoma : Chromaffin Granule Transmitters and Response to Treatment. Hypertension 36: 1045-1052 [Abstract] [Full Text]  
• Raber, W., Raffesberg, W., Bischof, M., Scheuba, C., Niederle, B., Gasic, S., Waldhausl, W., Roden, M. (2000). Diagnostic Efficacy of Unconjugated Plasma Metanephrines for the Detection of Pheochromocytoma. Arch Intern Med 160: 2957-2963 [Abstract] [Full Text]  
• Witteles, R. M., Kaplan, E. L., Roizen, M. F. (2000). Sensitivity of Diagnostic and Localization Tests for Pheochromocytoma in Clinical Practice. Arch Intern Med 160: 2521-2524 [Abstract] [Full Text]  
• KASHYAP, A S, KASHYAP, S. (2000). Phaeochromocytomas in VHL disease. Postgrad. Med. J. 76: 189d-189 [Full Text]  
• Wassell, J., Reed, P., Kane, J., Weinkove, C. (1999). Freedom from Drug Interference in New Immunoassays for Urinary Catecholamines and Metanephrines. Clin. Chem. 45: 2216-2223 [Abstract] [Full Text]